Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Smartscribe Reverse Transcriptase and Seqamp Dna Kits. The project location is USA and the tender is closing on 10 May 2024. The tender notice number is SS-NIAID-24-2215685, while the TOT Ref Number is 100740484. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Smartscribe Reverse Transcriptase and Seqamp Dna Kits
Deadline : 10 May 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 100740484
Document Ref. No. : SS-NIAID-24-2215685
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Sources Sought Announcement
Title: mRNA and cDNA Reagent Kits
ID: SS-NIAID-24-2215685
Post Date: April 30, 2024
Response Date: May 10, 2024
NAICS: 325414
Introduction
This is a Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement.
Background, Purpose, Objectives
The Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC Virology Laboratory comprises the Virology, Humoral Immunology, and Structural Biology Sections and related Cores. The goal of the Vaccine Immunology Laboratory is to conduct research to understand better the cellular and molecular regulation of viral gene expression, viral entry into the host cell, optimization of immune responses to gene-based vaccination and correlates of immune protection, assessment of active and passive approaches for HIV-1 vaccine development, and to apply structural biology techniques toward rational vaccine design for emerging and re-emerging infectious diseases.
The Vaccine Research Center is developing vaccines for HIV-1 and other viruses. Currently, SBS/SBIS is working on developing vaccines for SARS-CoV-2. Production of wild-type and mutant viral proteins and anti-viral antibodies is critical in vaccine development. Making specific immunogens as probes is critical to isolate antibodies and develop therapeutic agents in the Covid19 treatment.
The Virology Laboratory is interested in procuring the following biological supplies:
These reagents are used in cutting-edge techniques and technologies that are utilized in this project, including Illumina-s state-of-the-art NextSeq 1000 and NextSeq 2000 sequencing instruments. Only reagent...
Active Contract Opportunity Notice ID SS-NIAID-24-2215685 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 30, 2024 08:42 am EDT
Original Response Date: May 10, 2024 10:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 25, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Place of Performance: Gaithersburg, MD 20878 USA
Documents
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google